These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
521 related items for PubMed ID: 2185882
1. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene. Kaba DS, Pierceall WE, Price JE, Ananthaswamy HN. Cancer Res; 1990 Jun 01; 50(11):3159-66. PubMed ID: 2185882 [Abstract] [Full Text] [Related]
2. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells. Chen PW, Kaba DS, Ananthaswamy HN. Cancer Res; 1990 Mar 01; 50(5):1544-9. PubMed ID: 2137370 [Abstract] [Full Text] [Related]
3. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma. Fernandez A, Chen PW, Aggarwal BB, Ananthaswamy HN. Lymphokine Cytokine Res; 1992 Apr 01; 11(2):79-85. PubMed ID: 1581420 [Abstract] [Full Text] [Related]
8. Relationship between expression of tumor-specific transplantation antigens and neoplastic transformation in an ultraviolet radiation-induced murine skin cancer. Ananthaswamy HN. Cancer Res; 1986 Dec 01; 46(12 Pt 1):6322-6. PubMed ID: 3779649 [Abstract] [Full Text] [Related]
10. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities. Alon Y, Hammerling GJ, Segal S, Bar-Eli M. Cancer Res; 1987 May 15; 47(10):2553-7. PubMed ID: 3552201 [Abstract] [Full Text] [Related]
11. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones. Wortzel RD, Urban JL, Philipps C, Fitch FW, Schreiber H. J Immunol; 1983 May 15; 130(5):2461-6. PubMed ID: 6187859 [Abstract] [Full Text] [Related]
12. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors. Flood PM, Schreiber H, Ron Y. J Immunol; 1987 May 15; 138(10):3573-9. PubMed ID: 3571978 [Abstract] [Full Text] [Related]
13. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products. Caulín C, López-Barcons L, Gonzáles-Garrigues M, Navarro P, Lozano E, Rodrigo I, Gamallo C, Cano A, Fabra A, Quintanilla M. Mol Carcinog; 1996 Feb 15; 15(2):104-14. PubMed ID: 8599577 [Abstract] [Full Text] [Related]
14. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras. Price JE, Aukerman SL, Ananthaswamy HN, McIntyre BW, Schackert G, Schackert HK, Fidler IJ. Cancer Res; 1989 Aug 01; 49(15):4274-81. PubMed ID: 2663141 [Abstract] [Full Text] [Related]
15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG, Mohan RR, Katiyar SK, Wood GS, Bickers DR, Mukhtar H, Agarwal R. Mol Carcinog; 1996 Feb 01; 15(2):96-103. PubMed ID: 8599584 [Abstract] [Full Text] [Related]
16. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Fidler IJ, Li LM, Ananthaswamy HN, Esumi N, Radinsky R, Price JE. Anticancer Res; 1991 Feb 01; 11(1):17-24. PubMed ID: 2018350 [Abstract] [Full Text] [Related]